Hims & Hers Acquires Eucalyptus to Expand Canadian Healthcare Footprint — Hims & Hers Health, Inc.

Event summary

Hims & Hers completed the acquisition of Eucalyptus, parent company of Juniper, on June 2, 2026.
The deal accelerates Hims & Hers' push to transform healthcare access in Canada.
Juniper's weight management program will integrate with Hims & Hers' platform, expanding into sexual health and hair loss care.
Hims & Hers became the first platform to offer generic semaglutide in Canada in 2025.

The big picture

Hims & Hers' acquisition of Eucalyptus underscores its aggressive strategy to dominate the digital health space in Canada, addressing critical gaps in preventive care and chronic disease management. With nearly two-thirds of Canadian adults overweight or living with obesity, the deal positions Hims & Hers to capitalize on the growing demand for personalized, accessible healthcare solutions. The integration of Juniper's trusted weight management program could set a precedent for how digital health platforms expand into new therapeutic areas.

What we're watching

Integration Challenges: How Hims & Hers will merge Juniper's clinical support model with its existing infrastructure.
Market Penetration: Whether the acquisition will help Hims & Hers close gaps in prescription affordability and chronic disease management in Canada.
Regulatory Scrutiny: The pace at which regulatory changes in healthcare and privacy laws could impact Hims & Hers' operations in Canada.